live investor briefing 18th March, page-10

Had a quick listen to the webcast yesterday. The main takeaway is that SYC reiterated that there definitely will be some significant inflexion points in relation to the PTX trials this year, but doesn't want to repeat the previous strategy of highlighting indicative dates of results like last year (my read of that is to avoid a repeat of buying the rumour, selling the fact that happened last year).

also - looking to bring more of the PTX trials to Australia due to the low aussie dollar.

Finally, things happening with the Carina Bio CAR-T partnership, with further announcements this year.